OR WAIT null SECS
The platform is designed to match the most suitable drug delivery technologies to the API with the goal of providing optimal candidate formulations for animal pharmacokinetic studies.
Catalent Pharma Solutions is launching its new OptiForm Solution Suite platform at CPhI Worldwide 2015. The platform, which combines four technologies, including advanced parallel screening, is designed to match the most suitable drug delivery technologies to the API with the goal of providing optimal candidate formulations for animal pharmacokinetic studies in 12 weeks.
OptiForm Solution Suite aims to enhance drug bioavailability and to accelerate more molecules to the clinic and beyond.
Catalent is also showcasing several other advanced development and manufacturing technologies during the show, highlighting its tech transfer capabilities and flexible manufacturing solutions, including custom manufacturing suites, and the ability to handle cytotoxic and highly potent APIs. The company will detail how it has successfully combined these facilities and expertise to launch 175 new products to the market in 2014.
Catalent executives will be speaking at the Exhibitor Showcase:
Catalent is also participating in two Pharma Insight Briefings during the show:
Source: Catalent, Booth 3G10